Brokerages Set Integer Holdings Co. (NYSE:ITGR) Price Target at $146.56

Shares of Integer Holdings Co. (NYSE:ITGR) have been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $147.67.

A number of analysts have commented on the stock. Oppenheimer cut shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday. KeyCorp raised their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company reissued an “overweight” rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Benchmark raised their price objective on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday. Finally, Piper Sandler reissued an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th.

Institutional Trading of Integer

Hedge funds have recently added to or reduced their stakes in the company. Mather Group LLC. grew its holdings in Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 143 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of Integer in the fourth quarter valued at about $27,000. Huntington National Bank increased its position in Integer by 8,933.3% during the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after acquiring an additional 268 shares during the period. R Squared Ltd acquired a new stake in Integer in the 4th quarter worth about $44,000. Finally, Sterling Capital Management LLC boosted its holdings in Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 279 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Price Performance

NYSE:ITGR opened at $129.96 on Friday. Integer has a 52-week low of $98.63 and a 52-week high of $146.36. The company has a market cap of $4.36 billion, a P/E ratio of 40.11, a P/E/G ratio of 1.82 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The stock’s 50-day simple moving average is $137.92 and its 200 day simple moving average is $132.31.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The company had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. As a group, sell-side analysts forecast that Integer will post 5.33 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.